Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

globenewswire.com
EIKN

Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

prnewswire.com
WHWK

Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years

prnewswire.com
PGEN

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

globenewswire.com
BNTX BMY

ROSEN, A TOP RANKED LAW FIRM, Encourages UP Fintech Holding Limited Investors to Inquire About Securities Class Action Investigation - TIGR

accessnewswire.com
TIGR

The Killers triunfan en el espectáculo de la final de la UEFA Champions League presentado por Pepsi® USA - español Japan - Japanese India - English Korea - 한국어 USA - Français USA - Deutsch

prnewswire.com
PEP

THE KILLERS DONNENT LE COUP D'ENVOI DE LA FINALE DE LA LIGUE DES CHAMPIONS DE L'UEFA, PRÉSENTÉ PAR PEPSI® USA - Français India - English Japan - Japanese Korea - 한국어

prnewswire.com
PEP

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET

globenewswire.com
POET

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

globenewswire.com
NVDA

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VERI

accessnewswire.com
VERI
View all news →